Arca
Skip to content
Tools
Tools

Liver failure

Drug research and approvals for liver failure: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 121 studies of liver failure are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, FDA has 0 approved and 14 open orphan designations naming it, and the EU has 1 authorised medicine for it.

  • Recruiting worldwide: 121
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 1

Recruiting now

Newest posted first, of 121 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

  • TolcaponeCatechol O-methyltransferase inhibitor

Phase 3 3

Phase 2 4

Phase 1 or earlier 3

How its trials ended

450 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 77 whose ending is known, 35% met their primary endpoint, 3% missed it and 62% stopped early.

  • Completed, result not reported18641%
  • Status unknown10122%
  • Ongoing8619%
  • Stopped: other or unclear307%
  • Met its primary endpoint276%
  • Stopped: sponsor or business decision61%
  • Stopped: enrollment or feasibility51%
  • Stopped: lack of efficacy31%
  • Stopped: funding31%
  • Missed its primary endpoint2<1%
  • Stopped: safety1<1%

FDA orphan designations

Approved first, then open designations, newest first
Aug 10, 2026Selective inhibitor of dual-specific protein kinase…Prevention of post-hepatectomy liver failureHepaRegeniX GmbHDesignated
Mar 6, 2026NitazoxanideTreatment of acute-on-chronic liver failureGenfitDesignated
Jan 25, 2024Signal regulatory protein alpha (SIRPalpha)-ExosomeTreatment of acute liver failure regardless of etiologyShiftbio Inc.Designated
Sep 9, 2020Bioartificial liver system utilizing encapsulated human Hep…Treatment of Acute Liver failure.ESPL Regulatory Consulting LimitedDesignated
Jun 16, 2020GeranylgeranylacetonePrevention of post-hepatectomy liver failureRNR BioMedical Inc.Designated
Mar 15, 2018TrimetazidineTreatment of acute-on-chronic liver failureMartin Pharmaceuticals, Inc.Designated
Jun 21, 2017Citric acid monohydrateTreatment of acute-on-chronic liver failureGenfit SADesignated
Sep 13, 2011Cardiotrophin-1Treatment of acute liver failureDigna Biotech, S.L.Designated
May 11, 2011Human Hepatocarcinoma-Intestine-pancreas/pancreatitis…Treatment of acute liver failureVivo Bioscience Company LimitedDesignated
Apr 7, 2010L-ornithine phenylacetateTreatment of hyperammonemia and resultant hepatic encephalopathy (HE) in patients with acute liver failure or acute on chronic liver disaseAmalive LimitedDesignated
Jul 16, 2004Immortalized human liver cells found in the extracorporeal…Treatment of fulminant hepatic failure (acute liver failure)Vital Therapies, Inc.Designated
Sep 9, 2002N-acetylcysteineTreatment of acute liver failureCumberland Pharmaceuticals, Inc.Designated
Feb 11, 2002Bioartificial liver system utilizing xenogenic hepatocytes…Treatment of patients with acute liver failure presenting with encephalopathy deteriorating beyond Parson's grade 2Excorp Medical, Inc.Designated
Nov 27, 1998Xenogeneic hepatocytesTreatment of severe liver failure.Circe Biomedical, Inc.Designated

Medicines authorised in the EU

Newest first
AuthorisedMedicineHolderEPAR
Nov 30, 2009ZutectraHuman hepatitis B immunoglobulinBiotest Pharma GmbHEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.